SomnoMed Limited
OTC: SOMNF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Amrita Blickstead
- Employees
- 461
- Headquarters
- Crows Nest, Australia
- IPO year
- 2010
- Market cap
- $98.6M
- Website
- https://somnomed.com
Loading SOMNF…
Loading profile data…Frequently asked questions about SOMNF
What does SomnoMed Limited (SOMNF) do?
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company...
Where does SOMNF trade?
SomnoMed Limited (SOMNF) trades on the Other OTC.
What sector is SOMNF in?
SomnoMed Limited (SOMNF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of SomnoMed Limited?
Amrita Blickstead is the chief executive officer of SomnoMed Limited (SOMNF).
Where is SomnoMed Limited headquartered?
SomnoMed Limited is headquartered in Australia.
Does SOMNF pay a dividend?
SomnoMed Limited (SOMNF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SOMNF go public?
SomnoMed Limited (SOMNF) completed its initial public offering in 2010.